#hepatitis B

People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.

Fatal drug overdoses—mostly due to opioids, but also fentanyl, meth and prescription meds—spiked 28.5% during the COVID-19 pandemic.

Guidelines recommend that people with HIV should be vaccinated against HBV, but some do not respond well due to weakened immune function.

Since 1991, most children have been getting vaccinated against hepatitis B, so most adults under 30 are not at risk for the liver disease.

A decriminalization law in Maine allows people to have syringes. It’s an effort to combat rising overdose deaths and hepatitis C cases.

The funding, which also supports harm reduction, arrives from the NY attorney general’s settlements with opioid manufacturers.

A $6.6 million grant aims to integrate services for HIV, hepatitis B and C and substance misuse into primary care clinics across the state.

Take daily actions to support #NAIRHHA. For example: Advocate for HIV and hepatitis programs to include African dialects.

People who received a higher dose had stronger and longer-lasting immune responses.

Over 94,000 people died of drug overdoses in the U.S. last year. New York activists urge the new governor to OK overdose prevention centers.

Ballad Health warned clients of possible exposures to hepatitis B and C as well as HIV but said the risk was “extremely low.” [VIDEO]

Barriers still stand in the way of making treatment available to all who need it.

Hepatitis B and C kill more people each year than HIV/AIDS, malaria and TB. That’s why “Hepatitis Can’t Wait.”

Previous studies of the association between tenofovir and the coronavirus have yielded mixed results.

Despite a surge in HIV cases linked to injection drug use, the syringe exchange regulations were to take effect July 9.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.